I was listening to a task force report and then go
Post# of 9122
Debora Bird Elisa" and came up with this from March 23rd https://www.rev.com/blog/transcripts/donald-t...t-march-23
\
Deborah Birx: (01:08:07)
That’s what she was just asking about. These IgGs and IgM, both point of care, I can tell you it would be no problem making ELISA today, but then you’re drawing blood, you’re processing blood, you’re running plates. That’s what we did in the past. We really want a finger prick type assay where you can just put a fingerprint on and get your IgG and IgM, so that’s what we’re working on right now.
Reporter: (01:08:32)
Realistically, how long until that’s approved and available? Would you-
Deborah Birx: (01:08:35)
I can’t answer because I have to look at where each of the companies are that are in their development processes.
Reporter: (01:08:42)
It sounds like a while, then?
Deborah Birx: (01:08:44)
Well, there’s some that are developed now that they were using in Singapore, so we’re looking at those to see how those work.